ASO Visual Abstract: Venous Reconstruction During Pancreatectomy Using Polytetrafluoroethylene Grafts: A Single-Center Experience with Standardized Perioperative Management Jonathan GarnierEddy TraversariOlivier Turrini ASO Visual Abstract 08 April 2021 Pages: 5436 - 5437
Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which Is Worst? Giovanni Corso Breast Oncology 09 February 2021 Pages: 5438 - 5439
Reply to: Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst? Audree B. TadrosVaradan SevilimeduGeorge Plitas Breast Oncology 10 February 2021 Pages: 5440 - 5441
Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity? Todd M. TuttleJane Yuet Ching HuiJianling Yuan Breast Oncology 03 March 2021 Pages: 5442 - 5443
Response to Letter to the Editor: “Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?” by Todd Tuttle et al. James SunM. Catherine Lee Breast Oncology 18 February 2021 Pages: 5444 - 5445
COVID-19 and Cancer: Implications for Survival Analysis Francesca De FeliceFranco Moriconi Global Health Services Research 25 February 2021 Pages: 5446 - 5447
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation B. NoiretG. PiessenC. Eveno Peritoneal Surface Malignancy 20 February 2021 Pages: 5448 - 5449
Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” Philipp HorvathCan Yurttas Peritoneal Surface Malignancy Open access 26 February 2021 Pages: 5450 - 5451